The Richmond company (Nasdaq: BIOA) will get a fraction of the money upfront from Novartis (NYSE: NVS) — up to $20 million, ...

Alphabet spinoff SandboxAQ has raised more than $300 million to go toward developing AI applications across multiple areas ...

KalVista has an estimated pro forma cash balance of $292.2 million, which is expected to fund its operations into the 2H of ...

Mayor Brandon Scott released a draft of the city's plan to address the opioid crisis Wednesday, in keeping with an executive ...

The majority of Teva's business lies in generic and off-patent branded drugs and faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...

There is enormous potential in the development and use of AI in products liability mass and class actions, not yet as a ...

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from ...

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company ...

We believe there is enormous opportunity for us in the animal pharmaceuticals market, as there is a significant need to deliver medications more efficiently,” Gelteq co-founder and CEO Nathan Givoni ...

Tonix Pharmaceuticals Holding said the Food and Drug Administration has accepted its application seeking approval of its TNX-102 SL product candidate for the chronic pain condition fibromyalgia.

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in ...

IRVINE, CA / ACCESSWIRE / December 16, 2024 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today ...